Piper Sandler maintains Neutral on Vita Coco stock, $33 target

Published 27/03/2025, 14:20
Piper Sandler maintains Neutral on Vita Coco stock, $33 target

On Thursday, Piper Sandler maintained a Neutral rating on The Vita Coco Co. Inc (NASDAQ:COCO) with a set price target of $33.00. In response to a recent short report that led to an approximately 11% decline in Vita Coco’s share price - bringing its year-to-date return to -14.5% according to InvestingPro data - Piper Sandler addressed the concerns raised. Despite the recent volatility, the company maintains a "GREAT" financial health score of 3.52 out of 5. The short report had claimed that Vita Coco lost private label distribution, which appeared to be new information to the market.

Piper Sandler’s analyst engaged in discussions with Vita Coco and reported that the company’s situation remains consistent with previous statements. Vita Coco had already indicated the expectation of losing some regions with certain private label retailers during 2025. This anticipated change has been incorporated into the company’s outlook for 2025, which was reaffirmed today.

The analyst also noted Vita Coco’s strong supply chain, expressing skepticism that a competitor could match its scale in a cost-effective manner. Additionally, the analyst pointed out that since Vita Coco’s last report, sea freight rates have decreased, providing the company with cost advantages.

Despite the market’s reaction to the short report, Piper Sandler sees the recent pullback in Vita Coco’s shares as a potential buying opportunity. The firm suggests that there is approximately a 5% upside to its price target, which could materialize in the near term. With a P/E ratio of 34.3x and revenue growth of 4.5% in the last twelve months, investors seeking deeper insights can access comprehensive valuation metrics and 10 additional ProTips through InvestingPro’s detailed research report.

In other recent news, The Vita Coco Company reported fourth-quarter results that exceeded expectations, with adjusted earnings per share of $0.11, surpassing the analyst estimate of $0.07. Revenue for the quarter reached $127 million, beating the consensus estimate of $120.41 million and marking a 20% year-over-year increase. However, the company’s 2025 revenue guidance, projected between $555 million and $570 million, fell short of the analyst consensus midpoint of $569.4 million. Vita Coco also acknowledged inventory constraints and subpar service levels with private label retailers, anticipating potential contract losses with regional retailers in 2025.

Ningi Research announced a short position in Vita Coco, citing sluggish sales growth and a significant contract termination with Costco (NASDAQ:COST), which could lead to a $90 million revenue shortfall by the end of 2025. The research firm also highlighted Vita Coco’s declining market share and alleged mismanagement, including undisclosed related-party transactions and supply chain issues. Meanwhile, Jefferies adjusted its price target for Vita Coco to $42.00 from $43.00, maintaining a Buy rating based on robust sales and EBITDA figures that exceeded expectations. Jefferies noted that despite short-term challenges, Vita Coco’s capacity and inventory levels are stabilizing, with a positive outlook for the company’s future.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.